Adiponectin prevents atherosclerosis by increasing cholesterol efflux from macrophages
about
Adiponectin resistance in skeletal muscle: pathophysiological implications in chronic heart failurePotential Anti-Atherosclerotic Properties of AstaxanthinRole of adipokines in atherosclerosis: interferences with cardiovascular complications in rheumatic diseasesEndogenous bioactive peptides as potential biomarkers for atherosclerotic coronary heart diseaseEffect of apoA-I on cholesterol release and apoE secretion in human mature adipocytes.ATP-binding membrane cassette transporter A1 (ABCA1): a possible link between inflammation and reverse cholesterol transport.The reciprocal relationship between adiponectin and LOX-1 in the regulation of endothelial dysfunction in ApoE knockout miceEmerging role of adipokines as mediators in atherosclerosis.Adiponectin provides cardiovascular protection in metabolic syndrome.Adiponectin regulates vascular endothelial growth factor-C expression in macrophages via Syk-ERK pathway.Adiponectin levels and expression of adiponectin receptors in isolated monocytes from overweight patients with coronary artery diseaseAdiponectin receptor 2 deficiency results in reduced atherosclerosis in the brachiocephalic artery in apolipoprotein E deficient miceChemical Atherogenesis: Role of Endogenous and Exogenous Poisons in Disease Development.Lipids versus glucose in inflammation and the pathogenesis of macrovascular disease in diabetesExercise training improves endothelial function via adiponectin-dependent and independent pathways in type 2 diabetic mice.Pathophysiology of diabetic dyslipidaemia: where are we?Plasma total and high molecular weight adiponectin levels and risk of coronary heart disease in womenTotal and High Molecular Weight Adiponectin Levels and Prediction of Cardiovascular Risk in Diabetic PatientsPerivascular adipose tissue-derived adiponectin inhibits collar-induced carotid atherosclerosis by promoting macrophage autophagy.Effect of the Cannabinoid Receptor-1 antagonist SR141716A on human adipocyte inflammatory profile and differentiationAdiponectin and cardiovascular health: an updateAdipokines, diabetes and atherosclerosis: an inflammatory association.Dietary fat and carbohydrate modulate the effect of the ATP-binding cassette A1 (ABCA1) R230C variant on metabolic risk parameters in premenopausal women from the Genetics of Atherosclerotic Disease (GEA) StudySerum adiponectin in relation to race-ethnicity and vascular risk factors in the Northern Manhattan Study.Total adiponectin and risk of symptomatic lower extremity peripheral artery disease in men.Weight-Loss Diets, Adiponectin, and Changes in Cardiometabolic Risk in the 2-Year POUNDS Lost TrialImplications of serum paraoxonase activity in obesity, diabetes mellitus, and dyslipidemiaAnnexin A6 is highly abundant in monocytes of obese and type 2 diabetic individuals and is downregulated by adiponectin in vitroElective percutaneous coronary intervention leads to significant changes in serum resistin, leptin, and adiponectin levels regardless of periprocedural myocardial injury: an observational study.Adiponectin and adipocyte fatty acid binding protein in the pathogenesis of cardiovascular disease.Cannabinoids and atherosclerotic coronary heart disease.Adiponectin and lipoprotein metabolism.Mechanisms of adverse cardiometabolic consequences of obesity.Human paraoxonase-1 activity in childhood obesity and its relation to leptin and adiponectin levels.Oxyradical Stress, Endocannabinoids, and Atherosclerosis.Age and sex differences in serum adiponectin and its association with lipoprotein fractions.The evolving role of adiponectin as an additive biomarker in HFrEF.The expression of ATP-binding cassette transporter A1 in Chinese overweight and obese patients.Fibrates in the management of atherogenic dyslipidemia.Hepatic miR-33a/miR-144 and their target gene ABCA1 are associated with steatohepatitis in morbidly obese subjects.
P2860
Q26745026-85251E2A-FD7A-454B-A6C3-013B0C26A99BQ26767224-4A9B098F-1BAE-462E-86E9-0B342A640049Q27008359-32029F4A-4BF0-4C43-9A52-465120917250Q27010136-400EDC84-33FC-44BE-94C9-DACA0E119D3BQ34049704-2A12C182-D335-41A6-B9AB-05864DC3F3E9Q34112680-3B925B48-F90B-49B6-A1C7-6087F96ECAA5Q34150518-8C96864F-2E3B-4A89-9505-71AAF593A13CQ34427067-A730B96F-4AE9-4274-8912-F98C3861A36AQ34557564-119A4F1D-899D-4DA3-B79D-BF20CC2AC408Q34592720-1A34675D-309E-4B26-9DDA-01332E159088Q34592893-B79C6358-30A5-4CBC-8D95-B0400351C0E2Q35063642-AE130B1B-FE84-465F-8A58-A94CDA389FB0Q35099114-E118EE14-86C1-4934-B9D8-24DDC2394447Q35140825-47055BF4-E5C1-4A02-8DBF-A88210252F8AQ35159911-29746B28-9170-4978-8424-9B24D3D810A1Q35350326-BB80FDB9-CEEF-4E76-8A3B-57AF901E7814Q35501308-9CD5A1D3-47A9-450E-964D-9C6AC3E1FD63Q35620942-B4AF9FF0-863D-42C7-9638-45A142C16307Q35644649-96ADDBC6-5722-46FA-ADDA-E5954DDAE824Q35658286-6AE8ABC2-1008-4E8C-B018-9A13BA3E38D7Q35859734-6C3F87FB-05AB-4C01-860F-EA6B7BBDC0BFQ36241112-F924823F-6D36-4106-93BF-2301DEF4A469Q36287042-5B06C457-9B27-4E62-9972-82D0C824EF48Q36672456-41247DBA-057E-49D4-A1F7-DE6C773A5336Q36936176-6DD57565-C79C-4D37-90C4-6626BD0EF591Q36965307-87BA26DE-3D44-4615-B524-45E2E81EBDC0Q37015961-B7741CF3-0E21-4C17-996A-92F6BE60187BQ37290031-D1C7871C-33DE-473C-9A6B-122E19C033BFQ37664557-2D2AECC0-7243-40C2-BD10-017A06250D94Q37972596-E4C3BED3-2ECF-4142-92CD-1DD23417A70BQ37978806-1E3940B5-ED32-44E7-B50D-5FB649107BB6Q38129920-AF669525-16E8-4C12-B094-4853B0FC925FQ38139270-B7A2BA2A-878F-4E70-8DB7-57F09545E205Q38348866-E8818ACB-CCEB-4892-B1D0-9001A64EC749Q38678763-3725BE79-FDB9-4DC0-8A94-4B44A188508BQ38786124-28088DA2-0362-49AF-9430-B71D2D51D3D7Q38915167-1E260CFF-72D5-4B76-8559-BA744E819BACQ45968026-EE732A63-F7C0-4610-AC2B-F85990A28FE5Q49571281-7CEC6FB9-DC67-4308-A41D-DE0E59641382Q53156187-A43DF92C-6D6A-477B-9379-A9E5B572B999
P2860
Adiponectin prevents atherosclerosis by increasing cholesterol efflux from macrophages
description
2008 nî lūn-bûn
@nan
2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Adiponectin prevents atherosclerosis by increasing cholesterol efflux from macrophages
@ast
Adiponectin prevents atherosclerosis by increasing cholesterol efflux from macrophages
@en
Adiponectin prevents atherosclerosis by increasing cholesterol efflux from macrophages
@en-gb
Adiponectin prevents atherosclerosis by increasing cholesterol efflux from macrophages
@nl
type
label
Adiponectin prevents atherosclerosis by increasing cholesterol efflux from macrophages
@ast
Adiponectin prevents atherosclerosis by increasing cholesterol efflux from macrophages
@en
Adiponectin prevents atherosclerosis by increasing cholesterol efflux from macrophages
@en-gb
Adiponectin prevents atherosclerosis by increasing cholesterol efflux from macrophages
@nl
prefLabel
Adiponectin prevents atherosclerosis by increasing cholesterol efflux from macrophages
@ast
Adiponectin prevents atherosclerosis by increasing cholesterol efflux from macrophages
@en
Adiponectin prevents atherosclerosis by increasing cholesterol efflux from macrophages
@en-gb
Adiponectin prevents atherosclerosis by increasing cholesterol efflux from macrophages
@nl
P2093
P921
P1476
Adiponectin prevents atherosclerosis by increasing cholesterol efflux from macrophages
@en
P2093
Fumihiko Matsuura
Hajime Nakaoka
Hiroyuki Oku
Iichiro Shimomura
Jose C Sandoval
Kazuhiro Nakatani
Kazumi Tsubakio-Yamamoto
Makoto Nishida
Masahiro Koseki
Masato Ishigami
P304
P356
10.1016/J.BBRC.2008.08.009
P407
P577
2008-08-12T00:00:00Z